For some people, going on vacation by plane is really no fun. The difference in pressure causes them enormous earaches. And ...

On Wednesday, the House Labor, Health and Social Services Committee voted unanimously in favor of Senate File 74, “ Immunity ...

Tears were shed Friday at the Hawaii Island Fentanyl Task Force sign-waving rally as former addicts, victims, anti-drug ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...

Researchers at Texas A&M University College of Medicine have developed a new therapy that may slow the progression of ...

A Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...

Letters to the editors for the November 2024 issue of Scientific American ...

A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.